Peter Payne is a highly accomplished executive with over 30 years of leadership experience in the pharmaceutical, biotechnology, and contract research organization (CRO) industries. Known for his integrity and results-driven approach, Peter has successfully led organizations through periods of significant growth and transformation. With deep expertise in drug development, clinical trials, and corporate strategy, he has built a strong reputation for driving innovation and strategic partnerships. His leadership spans notable roles, including Vice President at Optum, President of Gennaker Bio, and CEO at multiple biotech companies. Peter’s ability to communicate complex strategies and foster cross-functional collaboration has made him a respected figure in the life sciences industry.

Michael Ekstut is a seasoned business leader with over 30 years of experience in the life sciences industry, specializing in drug discovery, development, and regulatory strategy. He has held senior leadership roles at industry-leading companies, including Certara, where he guided the company’s commercial and product strategy in the regulatory and access sector. Michael is known for his strategic vision and ability to drive innovation, optimizing clinical development programs and supporting biopharma companies in navigating complex regulatory landscapes. His deep expertise in business consulting, technology, and operational management has enabled him to successfully advise executives and investors across pharmaceuticals, biotechnology, and medical devices. Currently serving as a Senior Advisor at InSilicoTrials, Michael continues to leverage his vast experience to help organizations maximize the impact of their clinical development programs and investments.

Jeffrey Miller is a seasoned expert in governance, risk management, and compliance with over two decades of experience leading corporate compliance initiatives in the healthcare and life sciences industries. Currently serving as Director-in-Charge at Granite Governance, Risk and Compliance, LLC, Jeffrey has built a reputation for integrity and strategic leadership. His career spans senior roles at notable organizations including Saxton & Stump, LLC, Asterion Consulting, and Biomet 3i, where he oversaw complex compliance programs and corporate integrity agreements. Jeffrey’s deep knowledge of healthcare law and regulatory compliance is complemented by his ability to craft innovative solutions to navigate evolving legal landscapes. In addition to his executive roles, he contributes to the field as an adjunct professor at Villanova University and through publications on compliance and cybersecurity, reinforcing his position as a thought leader in the industry.

Nina Patel Lahanis is a senior executive with over 30 years of experience in the biopharma industry, specializing in pharmacovigilance, regulatory affairs, and operational management. Currently serving as Vice President at PrimeVigilance, Nina leads strategic initiatives to ensure compliance across the Americas, optimizing resources and driving technological innovation. Throughout her career, she has excelled in business development, client relationship management, and cross-functional leadership, with a proven track record of driving revenue growth and operational efficiencies. Nina’s global experience spans multiple regions, including India, Canada, and the UK, and her multilingual skills enable her to build strong, diverse relationships. She is deeply committed to advancing regulatory safety and compliance and is eager to lend her expertise to boards and advisory roles in the biopharma and life sciences sectors.

With over 15 years of experience in technology strategy and customer success, I am passionate about leveraging digital solutions to drive transformation in the life sciences industry. From leading global teams to implementing cutting-edge technologies, my focus has always been on delivering value and driving innovation. Here is my biography.

I am excited to share my professional journey, reflecting over 27 years of experience in the pharmaceutical and biotech sectors. From co-founding Vidara Therapeutics to leading commercialization efforts at Horizon and AVM Biotechnology, my passion for innovation and growth has been at the core of my work. Here is my biography.

I'm excited to share my journey in the life sciences sector! With over 39 years of experience leading risk management strategies for FDA-regulated companies, I’ve had the opportunity to help businesses navigate complex risks and regulatory challenges across industries like medical devices, biotech, pharmaceuticals, and clinical trials. At Hylant, I lead a team dedicated to building tailored risk management frameworks that allow our clients to focus on innovation while we manage the evolving market complexities. Integrity, perseverance, and paying it forward are values that have guided me throughout my career, and I’m passionate about supporting businesses as they grow and succeed in a distracted world. Let’s connect and explore how we can collaborate to protect and grow your business!

I’m excited to share my updated biography, highlighting my journey as an executive and board leader. Over the years, I’ve had the privilege of working across various industries, including life sciences, gaming, and manufacturing, where I’ve applied my expertise in financial management, mergers and acquisitions, and corporate governance. My career has been driven by a commitment to ethical leadership, strategic excellence, and clear communication, which I believe are essential for navigating complex challenges and fostering organizational growth. I’m proud of the contributions I’ve made and continue to make in shaping the future of business and finance.

🌟 Excited to share the impressive career journey of Michael Giske, a visionary leader in large-scale product engineering and technology implementations across high-tech, energy, automotive, and life sciences industries. His expertise in developing groundbreaking platforms like global Cancer Diagnostics & Genomic Analytics and IoT-based Telematics & Energy Solutions has driven multimillion-dollar revenues and enhanced scientific advancements worldwide. Michael's strategic prowess and strong P&L mindset continue to foster innovation and sustainable solutions, making him a driving force in global business development and IT leadership. Cheers to his ongoing success as Global CIO of B-ON and Chairman/President of Inomo Technologies!